For: | Triantafillidis JK, Zografos CG, Konstadoulakis MM, Papalois AE. Combination treatment of inflammatory bowel disease: Present status and future perspectives. World J Gastroenterol 2024; 30(15): 2068-2080 [PMID: 38681984 DOI: 10.3748/wjg.v30.i15.2068] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v30/i15/2068.htm |
Number | Citing Articles |
1 |
Galina V. Lukina, Oleg V. Knyazev, Elena A. Belousova, Diana I. Abdulganieva, Elena N. Aleksandrova, Igor G. Bakulin, Olga I. Barysheva, Maria А. Borisova, Bella А. Vykova, Alla А. Godzenko, Irina V. Gubonina, Tatiana V. Dubinina, Tatiana N. Zhigalova, Evgeny V. Zhilyaev, Anna V. Kagramanova, Tatiana V. Korotaeva, Alexander V. Kuzin, Maria A. Livzan, Aleksander M. Lila, Vadim I. Mazurov, Evgeny L. Nasonov, Alexander A. Novikov, Marina F. Osipenko, Asfold I. Parfenov, Larisa V. Tarasova, Olga V. Khlynova, Marina V. Shapina, Oksana B. Shchukina, Shandor F. Erdes, Aleksei A. Iakovlev. Russian Cross-disciplinary Consensus on the diagnosis and treatment of spondyloarthritis associated with inflammatory bowel diseases. Terapevticheskii arkhiv 2025; 97(2): 198 doi: 10.26442/00403660.2025.02.203117
|
2 |
Pengfei Zhang, Bing Pei, Chengxue Yi, Francis Atim Akanyibah, Fei Mao. The role of suppressor of cytokine signaling 3 in inflammatory bowel disease and its associated colorectal cancer. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2025; 1871(2): 167578 doi: 10.1016/j.bbadis.2024.167578
|
3 |
Mariam Narous, Zoann Nugent, Inna Rabinovich-Nikitin, Lorrie Kirshenbaum, Charles N Bernstein. Cardiac arrhythmia in patients with inflammatory bowel disease: a retrospective, population-based cohort study in Manitoba, Canada. BMJ Open 2025; 15(3): e097687 doi: 10.1136/bmjopen-2024-097687
|
4 |
Kristyna Gabova, Hana Bednarikova, Zdenek Meier, Peter Tavel. Exploring intimacy and family planning in Inflammatory Bowel Diseases: a qualitative study. Annals of Medicine 2024; 56(1) doi: 10.1080/07853890.2024.2401610
|
5 |
Jia-Wang Yan, Mei Nie, Hang Zhang, Yan-Miao Liu, Fu-Shan Tang. Strengths, weaknesses, opportunities, and threats analysis of combination therapy for inflammatory bowel disease. World Journal of Gastroenterology 2025; 31(9): 100607 doi: 10.3748/wjg.v31.i9.100607
|
6 |
Ya-Xiong Guo, Xiong Yan, Xu-Chang Liu, Yu-Xiang Liu, Chun Liu. Artificial intelligence-driven strategies for managing renal and urinary complications in inflammatory bowel disease. World Journal of Nephrology 2025; 14(1): 100825 doi: 10.5527/wjn.v14.i1.100825
|
7 |
Jeffrey A Lowell, Michael J Farber, Keith Sultan. Back to the drawing board: Overview of the next generation of combination therapy for inflammatory bowel disease. World Journal of Gastroenterology 2024; 30(25): 3182-3184 doi: 10.3748/wjg.v30.i25.3182
|
8 |
Andrzej S Tarnawski. Editor-in-Chief articles of choice and comments from January to June 2024. World Journal of Gastroenterology 2024; 30(34): 3875-3882 doi: 10.3748/wjg.v30.i34.3875
|
9 |
Antonio M Caballero-Mateos, Guillermo Arturo Cañadas-de la Fuente. Game changer: How Janus kinase inhibitors are reshaping the landscape of ulcerative colitis management. World Journal of Gastroenterology 2024; 30(35): 3942-3953 doi: 10.3748/wjg.v30.i35.3942
|
10 |
Alexandra Olate-Briones, Sofía Albornoz-Muñoz, Francisca Rodríguez-Arriaza, Valentina Rodríguez-Vergara, Juan Machuca Aguirre, Chaohong Liu, Carlos Peña-Farfal, Noelia Escobedo, Andrés A. Herrada. Yerba Mate (Ilex paraguariensis) Reduces Colitis Severity by Promoting Anti-Inflammatory Macrophage Polarization. Nutrients 2024; 16(11): 1616 doi: 10.3390/nu16111616
|
11 |
Wen-Ting Xie, Hui Yang, Lan Bai, Feng-Fei Wu. New perspectives and prospects for the next generation of combination therapy in inflammatory bowel disease. World Journal of Gastroenterology 2025; 31(5): 99462 doi: 10.3748/wjg.v31.i5.99462
|
12 |
Lucia Centanni, Clelia Cicerone, Fabrizio Fanizzi, Ferdinando D’Amico, Federica Furfaro, Alessandra Zilli, Tommaso Lorenzo Parigi, Laurent Peyrin-Biroulet, Silvio Danese, Mariangela Allocca. Advancing Therapeutic Targets in IBD: Emerging Goals and Precision Medicine Approaches. Pharmaceuticals 2025; 18(1): 78 doi: 10.3390/ph18010078
|
13 |
Mouhaned Y. Al-darwesh, Karukh Ali Babakr, Ibrahim Nazem Qader, Mohammed A. Mohammed. Antimicrobial, anti-inflammatory, and anticancer potential of green synthesis TiO2 nanoparticles using Sophora flavescens root extract. Chemical Papers 2025; 79(2): 1207 doi: 10.1007/s11696-024-03853-0
|
14 |
Barbara Macura, Aneta Kiecka, Marian Szczepanik. Intestinal permeability disturbances: causes, diseases and therapy. Clinical and Experimental Medicine 2024; 24(1) doi: 10.1007/s10238-024-01496-9
|
15 |
Lakshmi Thangavelu, Syam Mohan, Hassan A. Alfaifi, Abdullah Farasani, Soumya V. Menon, Pooja Bansal, Chhavi Choudhary, M Ravi Kumar, Raghav Vashishth, Afrah M.A. Al- Rihaymee, Sarvesh Rustagi, Anil K. Malhotra, Muhammed Shabil, Mahalaqua N. Khatib, Quazi S. Zahiruddin, Siddig I. Abdelwahab, Ganesh Bushi, Saleh H.A. Almasabi, Hayam A. Alrasheed, Ali A. Rabaan. Safety and efficacy of stem cell therapy for Crohn’s disease: an umbrella review of systematic reviews. International Journal of Surgery 2024; 110(12): 7495 doi: 10.1097/JS9.0000000000002104
|
16 |
Kazuo Yashima, Hiroki Kurumi, Naoyuki Yamaguchi, Hajime Isomoto. Progressing advanced therapies for inflammatory bowel disease: Current status including dual biologic therapy and discontinuation of biologics. Expert Review of Gastroenterology & Hepatology 2025; 19(3): 291 doi: 10.1080/17474124.2025.2469832
|
17 |
Wenqian Wang, Wenfu Cao, Shenyun Zhang, Dapeng Chen, Lihong Liu. The Role of Calprotectin in the Diagnosis and Treatment of Inflammatory Bowel Disease. International Journal of Molecular Sciences 2025; 26(5): 1996 doi: 10.3390/ijms26051996
|